Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "septin 8 pseudogene" (ENSG00000255457) designates a **pseudogene**, i.e., a non-functional genomic element that resembles the protein-coding gene SEPTIN8 (Septin-8), but does not produce a functional protein product[8]. Pseudogenes like this are typically considered "genomic fossils" and do not have direct biological, therapeutic, or pharmacological relevance; they do not encode active proteins, do not serve as receptors, enzymes, or transporters, and have no canonical functions or drug interactions, nor are they classified among therapeutic targets. Any biological or disease associations, interactions, or safety issues would pertain to the protein-coding **SEPTIN8** gene (not this pseudogene). As a result, this entry is **not a therapeutically relevant target**, and querying drug interactions or mechanisms of action is not applicable. **Key clarifications:** - The correct functional target would be **"Septin-8"** (SEPTIN8), which is a GTPase involved in cytoskeletal organization[3][4][6][2]. - The query refers to a **pseudogene**, not to the protein-coding gene or its product. - Pseudogenes may have potential regulatory roles at the RNA level (e.g., through competing endogenous RNA mechanisms), but these functions are generally considered speculative and rarely validated for therapeutic targeting[8]. **Summary:** The "septin 8 pseudogene" is a non-functional DNA sequence, not a therapeutic or druggable target. Any further data regarding molecular function, drug interactions, or mechanisms of action should be sought for the true protein-coding gene, **SEPTIN8/Septin-8**, but not for this pseudogene. If you require details for the active gene/protein "Septin-8" instead, please clarify the request.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 8 pseudogene.